Flutemetamol Completed Phase 2 Trials for Alzheimer's Disease (AD) / Healthy Subjects (HS) / Mild Cognitive Impairment (MCI) Diagnostic

Indications	Status	Purpose	Phase
DBCOND0049114 (Alzheimer's Disease (AD)) DBCOND0132512 (Healthy Subjects (HS)) DBCOND0038137 (Mild Cognitive Impairment (MCI))	Completed	Diagnostic	2

clinicaltrials.gov Identifier	Title	Drugs
NCT02813070	Comparison of PET Amyloid Imaging in Japanese and Western Subjects	Flutemetamol (DB15058)